Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: A multicenter active-surveillance report

Arthritis and Rheumatism

Volumn 48, Issue 8, 2003, Pages 2122-2127

  Gómez Reino, Juan J ^a,f   Carmona, Loreto ^b   Rodríguez Valverde, Vicente ^c   Mola, Emilio Martín ^d   Montero, Maria Dolores ^e  

^a Instituto de Salud Carlos III   (Spain)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^c HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^d HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^e Agencia Espanola del Medicamento   (Spain)

^f UNIDAD DE INVESTIGACIÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ETANERCEPT; INFLIXIMAB; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ANTIBODY;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; DATA BASE; DISEASE PREDISPOSITION; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; FEMALE; HUMAN; INCIDENCE; INFECTION; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SALMONELLA; SEPSIS; SKIN INFECTION; STAPHYLOCOCCUS; SURVIVAL RATE; THORAX RADIOGRAPHY; TUBERCULIN TEST; TUBERCULOSIS; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; VARICELLA ZOSTER VIRUS;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSION; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; TUBERCULOSIS, PULMONARY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0041653315     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.11137     Document Type: Article

References (15)

1. Lipsky PE, van der Heijde DM, St Clair EW, Furst DE, Breedveld FC, Kalden JR, et al, the Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med 2000;343:1594-602.
2. Maini R, St. Clair EW, Breedveld F, Furst D, Kalden J, Weisman M, et al, the ATTRACT Study Group. Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomized phase III trial. Lancet 1999;354:1932-9.
3. Taylor PC. Anti-tumor necrosis factor therapies. Curr Opin Rheumatol 2001;-13:164-9.
4. Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, et al. Tuberculosis associated with infliximab, a tumor necrosis factor a-neutralizing agent. N Engl J Med 2001;345:1098-104.
5. SESPAS (Sociedad Española de Salud Publica). 2002 SEPAS report: investing in health. In: Cabases JM, Villalbi JR, Aibar C, editors. Priorities for public health in Spain. Granada (Spain): Escuela Andaluza de Salud Publica; 2002. p. 21-42.
6. Carmona L, González-Álvaro I, Sanmartí R, Alejandro B, Tena X, Belmonte MA, et al, the EMECAR Study Group. Rheumatoid arthritis is associated to a four-fold increase in tuberculosis infection incidence in the pre-biologics era [abstract]. Arthritis Rheum 2001;44 Suppl 9:S173.
7. Phillips K, Husni ME, Karlson EW, Coblyn JS. Experience with etanercept in an academic medical center: are infection rates increased? Arthritis Care Res 2002;47:17-21.
8. Wolfe F, Flowers N, Anderson J, Urbansky K. Tuberculosis rates are not increased in rheumatoid arthritis (RA) [abstract]. Arthritis Rheum 2001;44 Suppl 9:S105.
9. Dursun AB, Kalac B, Yilmaz F. Pulmonary tuberculosis in patients with rheumatoid arthritis (four case reports). Rheumatol Int 2002:21:153-7.
10. Bynymin K, Cooper RG. Late reactivation of spinal tuberculosis by low-dose methotrexate therapy in a patient with rheumatoid arthritis. Rheumatology (Oxford) 2001;40:341-2.
11. Hernandez-Cruz B, Sifuentes-Osornio J, Ponce de Leon Garduno A, Diaz-Jouanen E. Mycobacterium tuberculosis infection in patients with systemic rheumatic diseases: a case-series. Clin Exp Rheumatol 1999;17:289-96.
12. Haas C, Youinou P. Tuberculosis and rheumatoid arthritis (a propos of 4 cases). Ann Med Interne (Paris) 1996;147:375-7.
13. Calpe J, Chiner E, Marin J, Martinez C, Lopez M, Sanchez E. Tuberculosis notification from 1987 to 1999 for the public health area of the community of Valencia (Spain). Arch Bronconeumol 2001;37:417-23.
14. Small P, Fujiwara PI. Management of tuberculosis in the United States. N Engl J Med 2001;345:189-200.
15. Wallis WJ, Burge DJ, Sabath D, Gardiner M. Tuberculosis reports with etanercept (Enbrel) therapy [abstract]. Arthritis Rheum 2001;44 Suppl 9:S78.